Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Next Generation Sequencing Analysis of B16F10.9 melanoma cells untreated or treated with IFN-gamma

ABSTRACT: We compare gene expression in B16F10.9 melanoma cells untreated or treated with IFN-gamma

ORGANISM(S): Mus musculus

PROVIDER: GSE106390 | GEO | 2018/05/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Next Generation Sequencing Analysis of B16F10.9 melanoma cells untreated or treated with IFN-gamma

Project description:Next Generation Sequencing Analysis of B16F10.9 melanoma cells untreated or treated with IFN-gamma

| PRJNA416699 | ENA

Differential expression of miRNAs in IFN-gamma treated SWAN-71 versus untreated control by next generation sequencing

Project description:The goal of this study is to compare miRNAs expressed by IFN-gamma treated SWAN-71 cells to miRNAs expressed in untreated control SWAN-71 cells to identify micro RNAs which play a role during IFN-gamma-mediated SWAN-71 cells invasion

2019-01-29 | GSE125789 | GEO

Differential expression of miRNAs in IFN-gamma treated HTR-8/SVneo versus untreated control by next generation sequencing

Project description:The goal of this study is to compare miRNAs expressed by IFN-gamma treated HTR-8/SVneo cells to miRNAs expressed in untreated control HTR-8/SVneo cells to identify micro RNAs which play a role during IFN-gamma-mediated HTR-8/SVneo cells invasion

2019-01-29 | GSE125774 | GEO

Differential expression of mRNAs in IFN-gamma treated HTR-8/SVneo versus untreated control by next generation sequencing

Project description:The goal of this study is to compare genes expressed by IFN-gamma treated HTR-8/SVneo cells to genes expressed in untreated control HTR-8/SVneo cells to identify genes which play a role during IFN-gamma-mediated HTR-8/SVneo cells invasion

2019-01-29 | GSE125778 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of IFN-γ induced-MMP2/9 inhibition compared to vehicle control cells' Transcriptomes

Project description:Expression profiles of SB-3CT treated A375 human melanoma cell lines and vehicle control group with or without induced by IFN-γ.

2020-09-03 | GSE141585 | GEO

JAK inhibition selectively suppresses melanoma lacking IFN-γ pathway

Project description:JAK inhibition selectively suppresses melanoma lacking IFN-γ pathway

| PRJNA828250 | ENA

CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens

Project description:In this study, we have identified candidates for IFN-γ-inducible CTLs-suppressive factors in melanoma cells using cDNA microarray analysis

2014-04-01 | GSE51259 | GEO

Differential expression of miRNAs in IFN-gamma treated SWAN-71 versus untreated control by next generation sequencing

Project description:Differential expression of miRNAs in IFN-gamma treated SWAN-71 versus untreated control by next generation sequencing

| PRJNA517507 | ENA

The expression profile of miRNA in response to IFN-γ-driven ferroptosis in melanoma

Project description:Anti-PD-1 immunotherapy has been established to be greatly effective in melanoma treatment, but the low response rate and occurrence of treatment resistance significantly hinder its efficacy. Recent studies have demonstrated that IFN-γ secreted by tumor-infiltrating CD8+T cells suppresses the expression of Xc- system to induce ferroptosis of tumor cells. However, whether the escape of tumor cells from ferroptosis facilitates the resistance to immunotherapy and the upstream regulatory mechanism remain elusive. MiRNAs participate in ferroptosis execution and can be delivered systemically by nanoparticle or alternative carriers, through which obvious therapeutic effect on cancer has been obtained. Herein, through RNA sequencing, we first obtained miRNAs expression profile of melanoma cells in IFN-γ-potentiated ferroptosis.

2022-06-29 | GSE186497 | GEO

human ESC-MSCs: IFN-γ-nontreated, IFN-γ-treated for 1 day, IFN-γ-treated for 3 days

Project description:human ESC-MSCs: IFN-γ-nontreated, IFN-γ-treated for 1 day, IFN-γ-treated for 3 days

| PRJNA503559 | ENA